Department of Neurological Surgery, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA.
Department of Neurological Surgery, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA; Department of Radiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA; Department of Neurology and Neuroscience, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA.
World Neurosurg. 2014 Jan;81(1):198-201. doi: 10.1016/j.wneu.2013.01.030. Epub 2013 Jan 11.
Gerard Percheron, M.D., a practicing neurologist and prolific researcher at the Institute Nationale de la Sante et de la Recherche Medicale (INSERM), made significant and valuable contributions to medicine, in particular, to the vascular anatomy of the basal ganglia. His particular interest in the thalamus eventually led to the identification of an anatomic variation in its vascular supply. This newly identified artery was subsequently named the artery of Percheron (AOP). Given the estimated prevalence of the AOP in up to one third of the population and its significant proportion of all thalamic infarcts, it is necessary for physicians to be aware of this anatomic vascular variant and its clinical consequences. Although occlusion of the AOP may present similar to other arterial thalamic occlusions, it can be identified through susceptibility-weighted imaging and ruled out with conventional or magnetic resonance angiography. Occlusion of the AOP typically causes a simultaneous and symmetric infarction. Treatment efficacy is time-dependent and necessitates thrombolytics and anticoagulative medications. Here, we trace a course from the artery's initial description in 1973 to its current implications in cerebrovascular stroke, and offer a synopsis of the proposed treatment.
杰勒德·佩尔谢隆(Gerard Percheron)医学博士,是一位执业神经科医生和 INSERM(法国国家健康与医学研究院)的多产研究员,他在医学方面,特别是在基底节血管解剖学方面做出了重大而有价值的贡献。他对丘脑的特殊兴趣最终导致了对其血管供应的一种解剖变异的识别。这条新识别的动脉随后被命名为佩尔谢隆动脉(AOP)。鉴于 AOP 在高达三分之一的人群中的估计患病率及其在所有丘脑梗死中的显著比例,医生有必要了解这种解剖血管变异及其临床后果。虽然 AOP 的闭塞可能与其他动脉性丘脑闭塞相似,但可以通过磁敏感加权成像识别,并通过常规或磁共振血管造影排除。AOP 的闭塞通常会导致同时且对称的梗死。治疗效果取决于时间,需要溶栓和抗凝药物。在这里,我们追溯了这条动脉从 1973 年首次描述到目前在脑血管中风中的应用的历程,并对提出的治疗方案进行了总结。